Effects of Long-Term Pamidronate Treatment on Bone Density and Fracture Rate in 65 Osteogenesis Imperfecta Patients

OBJECTIVE: Osteogenesis imperfecta (OI) is a clinically and genetically heterogeneous disease characterized by recurrent fractures, blue sclera, and hearing loss. Bisphosphonate treatment has been reported to decrease the annual number of fractures and improve the quality of life in patients with OI...

Descripción completa

Detalles Bibliográficos
Autores principales: Yazan, Hakan, Güneş, Nilay, Akpınar, Evren, Yıldırım, Timur, Nuri Özyalvaç, Osman, Uludağ Akkaya, Dilek, Tuysuz, Beyhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Pediatrics Association 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849351/
https://www.ncbi.nlm.nih.gov/pubmed/35110117
http://dx.doi.org/10.5152/TurkArchPediatr.2021.21077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849351/
https://www.ncbi.nlm.nih.gov/pubmed/35110117
http://dx.doi.org/10.5152/TurkArchPediatr.2021.21077

Ejemplares similares